STMN1 and ovarian carcinoma: Consistent with our results, STMN1 has been reported to be related to TX sensitivity in ovarian cancer and breast cancer as well [26, 51, 52], while targeting STMN1 by RNA interference can sensitize STMN1-overexpressing breast cancer cells to TX [26].